-

Globe Life Inc. (GL) Shareholder Alert: Robbins LLP Reminds Investors of its Investigation of the Officers and Directors of Globe Life Inc.

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Globe Life Inc. (NYSE: GL) to determine whether certain Globe Life officers and directors violated securities laws and breached fiduciary duties to shareholders in connection with allegations that the Company's agents engaged in a pattern of unchecked sexual assault and harassment. Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. It's largest subsidiary is American Income Life (AIL).

If you would like more information about our investigation of Globe Life Inc.'s misconduct submit a form, email Aaron Dumas, Jr., or give us a call at (800) 350-6003.

Globe Life Inc.'s (GL) Subsidiary is the Subject of a Lawsuit Alleging Sexual Assault and Harassment

According to an Insider article published in February 2023, AIL is the subject of a lawsuit filed by a female agent against AIL and her male managers. According to the article, female agents were the subject of sexual harassment, and aggressive, violent, and misogynistic behavior. They witnessed the open use of cocaine, steroids, male enhancement drugs, and other controlled substances. The article also details customer abuses and fraud. Top managers at AIL were allegedly aware of allegations of inappropriate sexual misconduct and drug abuse as far back as 2015, when a claim of misbehavior by top managers was escalated to AIL senior management. The article not only details explicit instances of misconduct by its star agents, but also references inappropriate conduct by AIL's senior executives.

Globe Life Inc. (GL) shareholders have legal options. If you own shares of Globe Life Inc., contact us for more information about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas, Jr.
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Globe Life Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:GL

Release Summary
Globe Life Inc.'s (GL) Subsidiary is the Subject of a Lawsuit Alleging Sexual Assault and Harassment
Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom